GR3015685T3 - 5-Aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders. - Google Patents
5-Aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders.Info
- Publication number
- GR3015685T3 GR3015685T3 GR950400832T GR950400832T GR3015685T3 GR 3015685 T3 GR3015685 T3 GR 3015685T3 GR 950400832 T GR950400832 T GR 950400832T GR 950400832 T GR950400832 T GR 950400832T GR 3015685 T3 GR3015685 T3 GR 3015685T3
- Authority
- GR
- Greece
- Prior art keywords
- triazol
- aryl
- ones
- treatment
- neurodegenerative disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94463486A | 1986-12-19 | 1986-12-19 | |
US10700187A | 1987-10-16 | 1987-10-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3015685T3 true GR3015685T3 (en) | 1995-07-31 |
Family
ID=26804275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR950400832T GR3015685T3 (en) | 1986-12-19 | 1995-04-04 | 5-Aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0273309B1 (el) |
JP (1) | JP2593084B2 (el) |
KR (1) | KR880007495A (el) |
AT (1) | ATE116851T1 (el) |
DE (1) | DE3750979T2 (el) |
DK (1) | DK172668B1 (el) |
ES (1) | ES2069528T3 (el) |
GR (1) | GR3015685T3 (el) |
IE (1) | IE65857B1 (el) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4966909A (en) * | 1989-12-20 | 1990-10-30 | Merrell Dow Pharmaceuticals | 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants |
AU644500B2 (en) * | 1990-12-20 | 1993-12-09 | Merrell Dow Pharmaceuticals Inc. | 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma |
US5840746A (en) * | 1993-06-24 | 1998-11-24 | Merck Frosst Canada, Inc. | Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
DE19816882A1 (de) * | 1998-04-17 | 1999-10-21 | Boehringer Ingelheim Pharma | Triazolone mit neuroprotektiver Wirkung |
TW200505441A (en) | 2003-03-24 | 2005-02-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitorsⅠ |
RU2394028C2 (ru) | 2004-07-27 | 2010-07-10 | Ф.Хоффманн-Ля Рош Аг | Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы |
US8293778B2 (en) | 2004-07-27 | 2012-10-23 | Roche Palo Alto Llc | Heterocyclic antiviral compounds |
JP2010522706A (ja) | 2007-03-29 | 2010-07-08 | エフ.ホフマン−ラ ロシュ アーゲー | 非ヌクレオシド逆転写酵素阻害剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1126882B (de) * | 1960-05-03 | 1962-04-05 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von 1,2,4-Triazolonen-(5) |
BE621842A (el) * | 1962-08-27 | |||
DE1545646B1 (de) * | 1965-12-15 | 1969-09-18 | Boehringer Sohn Ingelheim | 1,3-Dimethyl-4-(2',4'-dichlorphenyl)-1,2,4-triazolon-(5) und Verfahren zu dessen Herstellung |
DD153953A3 (de) * | 1980-04-01 | 1982-02-17 | Gottfried Schuster | Mittel zur chemotherapie von virosen der kulturpflanzen |
DD160447A1 (de) * | 1981-03-26 | 1983-08-03 | Johannes Dost | Herbizide mittel, die 1,2,4-triazolinone-(5) enthalten |
AR243171A1 (es) * | 1985-10-29 | 1993-07-30 | Merrell Pharma Inc | Procedimiento para preparar 5-aril-2,4-dialquil-3h-1,2,4-triazol-3-tionas. |
-
1987
- 1987-12-15 JP JP62315427A patent/JP2593084B2/ja not_active Expired - Lifetime
- 1987-12-17 ES ES87118727T patent/ES2069528T3/es not_active Expired - Lifetime
- 1987-12-17 DE DE3750979T patent/DE3750979T2/de not_active Expired - Fee Related
- 1987-12-17 AT AT87118727T patent/ATE116851T1/de not_active IP Right Cessation
- 1987-12-17 EP EP87118727A patent/EP0273309B1/en not_active Expired - Lifetime
- 1987-12-18 DK DK198706711A patent/DK172668B1/da not_active IP Right Cessation
- 1987-12-18 IE IE345987A patent/IE65857B1/en not_active IP Right Cessation
- 1987-12-19 KR KR870014559A patent/KR880007495A/ko not_active Application Discontinuation
-
1995
- 1995-04-04 GR GR950400832T patent/GR3015685T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR880007495A (ko) | 1988-08-27 |
IE873459L (en) | 1989-04-16 |
DK671187A (da) | 1988-06-20 |
EP0273309A3 (en) | 1991-01-09 |
JP2593084B2 (ja) | 1997-03-19 |
DK172668B1 (da) | 1999-05-10 |
ATE116851T1 (de) | 1995-01-15 |
DK671187D0 (da) | 1987-12-18 |
ES2069528T3 (es) | 1995-05-16 |
EP0273309A2 (en) | 1988-07-06 |
DE3750979D1 (de) | 1995-02-23 |
EP0273309B1 (en) | 1995-01-11 |
DE3750979T2 (de) | 1995-05-24 |
JPS63170312A (ja) | 1988-07-14 |
IE65857B1 (en) | 1995-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3005447T3 (el) | ||
IN172468B (el) | ||
EP0335901A4 (en) | Methods and compositions for the treatment of non-ige-mediated diseases | |
EP0945135A3 (en) | Treatment of alzheimer's disease and modulation of immune system with Delta5-Androstenes | |
DE68900371D1 (de) | Textile struktur zur herstellung von schichtstoffen und schichtformteile, die diese struktur enthalten. | |
CA2192480A1 (en) | Benzopyrans and their use as therapeutic agents | |
GR3015685T3 (en) | 5-Aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders. | |
PH24094A (en) | 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
ZA9010080B (en) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
GR78135B (el) | ||
GR3007508T3 (el) | ||
HRP940210A2 (en) | New imidazoloquinoxalinones their production and use | |
ES8502103A1 (es) | Procedimiento para la obtencion de amidas del acido piperazin-1-il-acetico substituido | |
AU603375B2 (en) | Therapeutic agent for the treatment of disorders associated with cerebral ischemia | |
ATE90562T1 (de) | Antiepileptisch wirkende pyrazolopyridine. | |
MA23098A1 (fr) | Composition therapeutique nouvelle remediant aux desordres survenant dans la sphere orl . | |
IT8464319V0 (it) | Bottale con superficie munita di aperture adatte all'eliminazione del sale e di altre impurita' nelle pelli salate. | |
GB8618614D0 (en) | Treatment of psychiatric disorders | |
IE880441L (en) | Treating coronary or cerebral disorders |